MENU

Fox Chase Cancer Center News

Abhishek Aphale, MD
July 21, 2016

Abhishek Aphale, MD, Joins Department of Dermatology at Fox Chase Cancer Center

PHILADELPHIA (July 21, 2016) — Abhishek Aphale, MD, has been appointed Assistant Professor of Dermatology at Fox Chase Cancer Center. He specializes in Mohs surgery and reconstruction and cutaneous oncology.

Rajeswari Nagarathinam, MD
July 15, 2016

Rajeswari Nagarathinam, MD, Joins Department of Pathology at Fox Chase Cancer Center

PHILADELPHIA (July 15, 2016) — Rajeswari Nagarathinam, MD, has joined the department of pathology at Fox Chase Cancer Center, focusing on both surgical pathology and cytopathology.

July 6, 2016

Researchers from Fox Chase Cancer Center Identify ERC33-MYC as a Target in Pancreatic Cancer

PHILADELPHIA (July 6, 2016) – The protein coding gene ERC33-MYC has been identified as a target in pancreatic cancer by researchers from Fox Chase Cancer Center - Temple Health.

June 24, 2016

Shuanzeng (Sam) Wei, MD, PhD, Joins Fox Chase Department of Pathology

PHILADELPHIA (June 24, 2016) — Shuanzeng (Sam) Wei, MD, PhD, has joined the department of pathology at Fox Chase Cancer Center as an assistant professor, where he will specialize in surgical pathology and cytopathology.

June 24, 2016

Philip A. Pancari, MD, Joins the Fox Chase–Temple University Hospital BMT Program

PHILADELPHIA (June 24, 2016) — Philip A. Pancari, MD, has joined the department of hematology/oncology at Fox Chase Cancer Center, providing additional physician support for the Fox Chase Cancer Center–Temple University Hospital Bone Marrow Transplant (BMT) Program.

Cancer Moonshot Summit 2016, Region 3
June 21, 2016

Fox Chase Cancer Center to Host Regional Cancer Moonshot Summit

PHILADELPHIA (June 21, 2016) — Fox Chase Cancer Center, in partnership with the American Cancer Society and the U.S. Department of Health and Human Services, will host the Regional Summit for Region III on June 29th, in conjunction with the Cancer Moonshot Summit held at Howard University, Washington DC.

June 15, 2016

Fox Chase Cancer Center Celebrates Survivors During Cancer Survivorship Month

PHILADELPHIA (June 15, 2016) — June is National Cancer Survivorship Month. This month, Fox Chase Cancer Center physicians celebrate individuals who have overcome cancer while emphasizing the importance of staying healthy after completing cancer treatment.

Hossein Borghaei, DO, chief of medical oncology at Fox Chase
May 25, 2016

An Immunotherapy Drug, OPDIVO®, Is Found To Improve Long-Term Overall Survival for Patients with Advanced Lung Cancer

PHILADELPHIA (May 25, 2016) — In a study of those patients with advanced non-squamous non-small cell lung cancer (NSCLC), those treated with the drug OPDIVO® (nivolumab) demonstrated improved overall survival over patients treated with the drug Taxotere® (docetaxel). 

Pages